Cardiovascular Diseases Clinical Trials in San Francisco, California

7 studies are recruiting for cardiovascular diseases in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Secondhand Tobacco Smoke and Cardiovascular Disease

   This is a double-blind randomized placebo-controlled crossover clinical trial of efficacy and safety of an FDA-approved angiotensin receptor blocker (losartan) to improve cardiopulmonary outcomes in individuals with pre-Chronic Obstructive Pulmonary Disease (COPD) due to prolonged exposure to secon…

   Stage

   Phase 4

   Ages

   40 and older

   Site

   San Francisco Veterans' Affairs Medical Center, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT04715568 on ClinicalTrials.gov

2. Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans

   Home-based CR (HBCR) is an alternative to traditional CR programs that has comparable efficacy in improving morbidity/mortality and increases access to critical services. There is major potential to improve Veteran engagement in CR by combining digital coaching (d-Coaching) with existing VA-support…

   Stage

   Not phased

   Ages

   21 and older

   Site

   San Francisco VA Medical Center, San Francisco, CA, San Francisco, California

   Locations

   2 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05423158 on ClinicalTrials.gov

3. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

   The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California at San Francisco, San Francisco, California

   Locations

   68 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT06526195 on ClinicalTrials.gov

4. The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

   The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California- San Francisco, San Francisco, California

   Locations

   92 in total

   Run by

   Cardiac Dimensions, Inc.

   See if you can join NCT03142152 on ClinicalTrials.gov

5. Patient Care Outreach, Navigation, Technology and Support 2.0

   This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserv…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Zuckerberg San Francisco General Hospital, San Francisco, California

   Locations

   2 in total

   Run by

   University of California, San Francisco

   See if you can join NCT06648278 on ClinicalTrials.gov

6. Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

   This is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, immune activation, …

   Stage

   Phase 2

   Ages

   40 and older

   Site

   San Francisco General Hospital, San Francisco, California

   Locations

   3 in total

   Run by

   Priscilla Hsue, MD

   See if you can join NCT05488431 on ClinicalTrials.gov

7. Text Education About Cardiovascular Health and HIV (TEACH-HIV)

   The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

   Stage

   Not phased

   Ages

   40 and older

   Site

   Zuckerberg San Francisco General Hospital, San Francisco, California

   Locations

   2 in total

   Run by

   University of California, San Francisco

   See if you can join NCT05642858 on ClinicalTrials.gov